United StatesMemantine Hydrochloride Extended‑Release capsules, 7 mg, 100‑count (10 x 10 blister packs), NDC 0904-6734-61, Lot # N02425, Exp. 05/31/2027, packaged and distributed by Major Pharmaceuticals and recalled by The Harvard Drug Group LLC. They were recalled because they failed dissolution specifications. The product was sold nationwide in the United States.
What's being recalled
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
Recalling firm: The Harvard Drug Group LLC, Dublin, OH, United States.
How to identify it
Lot # N02425, Exp Date: 05/31/2027.
The hazard
Failed Dissolution Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)